Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Enterotoxigenic Escherichia coli-blood group A interactions intensify diarrheal severity.

Kumar P, Kuhlmann FM, Chakraborty S, Bourgeois AL, Foulke-Abel J, Tumala B, Vickers TJ, Sack DA, DeNearing B, Harro CD, Wright WS, Gildersleeve JC, Ciorba MA, Santhanam S, Porter CK, Gutierrez RL, Prouty MG, Riddle MS, Polino A, Sheikh A, Donowitz M, Fleckenstein JM.

J Clin Invest. 2019 Jul 1;129(7):2980. doi: 10.1172/JCI130874. Epub 2019 Jul 1. No abstract available.

2.

Molecular Determinants of Enterotoxigenic Escherichia coli Heat-Stable Toxin Secretion and Delivery.

Zhu Y, Luo Q, Davis SM, Westra C, Vickers TJ, Fleckenstein JM.

Infect Immun. 2018 Oct 25;86(11). pii: e00526-18. doi: 10.1128/IAI.00526-18. Print 2018 Nov.

3.

Human Experimental Challenge With Enterotoxigenic Escherichia coli Elicits Immune Responses to Canonical and Novel Antigens Relevant to Vaccine Development.

Chakraborty S, Randall A, Vickers TJ, Molina D, Harro CD, DeNearing B, Brubaker J, Sack DA, Bourgeois AL, Felgner PL, Liang X, Mani S, Wenzel H, Townsend RR, Gilmore PE, Darsley MJ, Rasko DA, Fleckenstein JM.

J Infect Dis. 2018 Sep 22;218(9):1436-1446. doi: 10.1093/infdis/jiy312.

PMID:
29800314
4.

Enterotoxigenic Escherichia coli-blood group A interactions intensify diarrheal severity.

Kumar P, Kuhlmann FM, Chakraborty S, Bourgeois AL, Foulke-Abel J, Tumala B, Vickers TJ, Sack DA, DeNearing B, Harro CD, Wright WS, Gildersleeve JC, Ciorba MA, Santhanam S, Porter CK, Gutierrez RL, Prouty MG, Riddle MS, Polino A, Sheikh A, Donowitz M, Fleckenstein JM.

J Clin Invest. 2018 Aug 1;128(8):3298-3311. doi: 10.1172/JCI97659. Epub 2018 Jun 25. Erratum in: J Clin Invest. 2019 Jul 1;129(7):2980.

5.

A Role for Salivary Peptides in the Innate Defense Against Enterotoxigenic Escherichia coli.

Brown JW, Badahdah A, Iticovici M, Vickers TJ, Alvarado DM, Helmerhorst EJ, Oppenheim FG, Mills JC, Ciorba MA, Fleckenstein JM, Bullitt E.

J Infect Dis. 2018 Apr 11;217(9):1435-1441. doi: 10.1093/infdis/jiy032.

6.

Immunogenicity and Protective Efficacy against Enterotoxigenic Escherichia coli Colonization following Intradermal, Sublingual, or Oral Vaccination with EtpA Adhesin.

Luo Q, Vickers TJ, Fleckenstein JM.

Clin Vaccine Immunol. 2016 Jul 5;23(7):628-37. doi: 10.1128/CVI.00248-16. Print 2016 Jul.

7.

Enterotoxigenic Escherichia coli secretes a highly conserved mucin-degrading metalloprotease to effectively engage intestinal epithelial cells.

Luo Q, Kumar P, Vickers TJ, Sheikh A, Lewis WG, Rasko DA, Sistrunk J, Fleckenstein JM.

Infect Immun. 2014 Feb;82(2):509-21. doi: 10.1128/IAI.01106-13. Epub 2013 Nov 18.

8.

EatA, an immunogenic protective antigen of enterotoxigenic Escherichia coli, degrades intestinal mucin.

Kumar P, Luo Q, Vickers TJ, Sheikh A, Lewis WG, Fleckenstein JM.

Infect Immun. 2014 Feb;82(2):500-8. doi: 10.1128/IAI.01078-13. Epub 2013 Nov 11.

9.

Folate metabolic pathways in Leishmania.

Vickers TJ, Beverley SM.

Essays Biochem. 2011;51:63-80. doi: 10.1042/bse0510063. Review.

10.

Wikipedia: a key tool for global public health promotion.

Heilman JM, Kemmann E, Bonert M, Chatterjee A, Ragar B, Beards GM, Iberri DJ, Harvey M, Thomas B, Stomp W, Martone MF, Lodge DJ, Vondracek A, de Wolff JF, Liber C, Grover SC, Vickers TJ, Meskó B, Laurent MR.

J Med Internet Res. 2011 Jan 31;13(1):e14. doi: 10.2196/jmir.1589.

11.

A role for tetrahydrofolates in the metabolism of iron-sulfur clusters in all domains of life.

Waller JC, Alvarez S, Naponelli V, Lara-Nuñez A, Blaby IK, Da Silva V, Ziemak MJ, Vickers TJ, Beverley SM, Edison AS, Rocca JR, Gregory JF 3rd, de Crécy-Lagard V, Hanson AD.

Proc Natl Acad Sci U S A. 2010 Jun 8;107(23):10412-7. doi: 10.1073/pnas.0911586107. Epub 2010 May 20.

12.

Identification of transport-critical residues in a folate transporter from the folate-biopterin transporter (FBT) family.

Eudes A, Kunji ER, Noiriel A, Klaus SM, Vickers TJ, Beverley SM, Gregory JF 3rd, Hanson AD.

J Biol Chem. 2010 Jan 22;285(4):2867-75. doi: 10.1074/jbc.M109.063651. Epub 2009 Nov 18.

13.

The enzymes of the 10-formyl-tetrahydrofolate synthetic pathway are found exclusively in the cytosol of the trypanosomatid parasite Leishmania major.

Vickers TJ, Murta SM, Mandell MA, Beverley SM.

Mol Biochem Parasitol. 2009 Aug;166(2):142-52. doi: 10.1016/j.molbiopara.2009.03.009. Epub 2009 Apr 5.

14.

PTR1-dependent synthesis of tetrahydrobiopterin contributes to oxidant susceptibility in the trypanosomatid protozoan parasite Leishmania major.

Nare B, Garraway LA, Vickers TJ, Beverley SM.

Curr Genet. 2009 Jun;55(3):287-99. doi: 10.1007/s00294-009-0244-z. Epub 2009 Apr 25.

15.

Seeking health information online: does Wikipedia matter?

Laurent MR, Vickers TJ.

J Am Med Inform Assoc. 2009 Jul-Aug;16(4):471-9. doi: 10.1197/jamia.M3059. Epub 2009 Apr 23.

16.

Methylene tetrahydrofolate dehydrogenase/cyclohydrolase and the synthesis of 10-CHO-THF are essential in Leishmania major.

Murta SM, Vickers TJ, Scott DA, Beverley SM.

Mol Microbiol. 2009 Mar;71(6):1386-401. doi: 10.1111/j.1365-2958.2009.06610.x. Epub 2009 Jan 16.

17.

A gene wiki for community annotation of gene function.

Huss JW 3rd, Orozco C, Goodale J, Wu C, Batalov S, Vickers TJ, Valafar F, Su AI.

PLoS Biol. 2008 Jul 8;6(7):e175. doi: 10.1371/journal.pbio.0060175. No abstract available.

18.

Roles of trypanothione S-transferase and tryparedoxin peroxidase in resistance to antimonials.

Wyllie S, Vickers TJ, Fairlamb AH.

Antimicrob Agents Chemother. 2008 Apr;52(4):1359-65. doi: 10.1128/AAC.01563-07. Epub 2008 Feb 4.

19.

The role of the mitochondrial glycine cleavage complex in the metabolism and virulence of the protozoan parasite Leishmania major.

Scott DA, Hickerson SM, Vickers TJ, Beverley SM.

J Biol Chem. 2008 Jan 4;283(1):155-65. Epub 2007 Nov 2.

20.

Biochemical and genetic analysis of methylenetetrahydrofolate reductase in Leishmania metabolism and virulence.

Vickers TJ, Orsomando G, de la Garza RD, Scott DA, Kang SO, Hanson AD, Beverley SM.

J Biol Chem. 2006 Dec 15;281(50):38150-8. Epub 2006 Oct 10.

21.

Trypanothione-dependent glyoxalase I in Trypanosoma cruzi.

Greig N, Wyllie S, Vickers TJ, Fairlamb AH.

Biochem J. 2006 Dec 1;400(2):217-23.

22.

Crystallization and preliminary X-ray analysis of Leishmania major glyoxalase I.

Ariza A, Vickers TJ, Greig N, Fairlamb AH, Bond CS.

Acta Crystallogr Sect F Struct Biol Cryst Commun. 2005 Aug 1;61(Pt 8):769-72. Epub 2005 Jul 30.

23.

Specificity of the trypanothione-dependent Leishmania major glyoxalase I: structure and biochemical comparison with the human enzyme.

Ariza A, Vickers TJ, Greig N, Armour KA, Dixon MJ, Eggleston IM, Fairlamb AH, Bond CS.

Mol Microbiol. 2006 Feb;59(4):1239-48.

24.

A trypanothione-dependent glyoxalase I with a prokaryotic ancestry in Leishmania major.

Vickers TJ, Greig N, Fairlamb AH.

Proc Natl Acad Sci U S A. 2004 Sep 7;101(36):13186-91. Epub 2004 Aug 25.

25.

Leishmania major elongation factor 1B complex has trypanothione S-transferase and peroxidase activity.

Vickers TJ, Wyllie S, Fairlamb AH.

J Biol Chem. 2004 Nov 19;279(47):49003-9. Epub 2004 Aug 18.

26.

Two interacting binding sites for quinacrine derivatives in the active site of trypanothione reductase: a template for drug design.

Saravanamuthu A, Vickers TJ, Bond CS, Peterson MR, Hunter WN, Fairlamb AH.

J Biol Chem. 2004 Jul 9;279(28):29493-500. Epub 2004 Apr 21.

27.

Trypanothione S-transferase activity in a trypanosomatid ribosomal elongation factor 1B.

Vickers TJ, Fairlamb AH.

J Biol Chem. 2004 Jun 25;279(26):27246-56. Epub 2004 Apr 8.

28.

Characterization of C18-bonded liquid chromatographic stationary phases by Raman spectroscopy: the effect of temperature.

Doyle CA, Vickers TJ, Mann CK, Dorsey JG.

J Chromatogr A. 2000 Apr 28;877(1-2):41-59.

PMID:
10845788
29.

Characterization of C18-bonded liquid chromatographic stationary phases by Raman spectroscopy: the effect of mobile phase composition.

Doyle CA, Vickers TJ, Mann CK, Dorsey JG.

J Chromatogr A. 2000 Apr 28;877(1-2):25-39.

PMID:
10845787
30.

Direct assay and shelf-life monitoring of aspirin tablets using Raman spectroscopy.

Wang C, Vickers TJ, Mann CK.

J Pharm Biomed Anal. 1997 Sep;16(1):87-94.

PMID:
9447555
31.

Characterization of liquid chromatographic stationary phases by Raman spectroscopy. Effect of ligand type.

Doyle CA, Vickers TJ, Mann CK, Dorsey JG.

J Chromatogr A. 1997 Aug 29;779(1-2):91-112.

PMID:
9335120
32.
33.

Optical emission spectroscopy with a microwave-induced plasma in a sealed microtube.

Holman DW, Vickers TJ.

Talanta. 1982 May;29(5):419-21.

PMID:
18963153
34.

Determination of copper and iron in microliter samples by flame atomic emission spectrometry with a tantalum filament vaporizer.

McCullough MR, Vickers TJ.

Anal Chem. 1976 Jun;48(7):1006-8. No abstract available.

PMID:
1267168
35.
36.

Determination of iron in serum by atomic fluorescence flame spectrometry.

Rippetoe WE, Muscat VI, Vickers TJ.

Anal Chem. 1974 May;46(6):796. No abstract available.

PMID:
4825970
37.

Flame spectrometry.

Winefordner JD, Vickers TJ.

Anal Chem. 1972 Apr 1;44(5):150-82. doi: 10.1021/ac60313a034. No abstract available.

PMID:
22401007
38.

Supplemental Content

Loading ...
Support Center